Literature DB >> 3620961

Self-administration of morphine into the lateral hypothalamus in the mouse.

P Cazala, C Darracq, M Saint-Marc.   

Abstract

BALB/c mice were chronically and unilaterally implanted with a guide cannula, the tip of which was positioned 1 mm above the lateral hypothalamus (LH). On each experimental day, a stainless-steel injection cannula was inserted into the LH, and self-administration of morphine or vehicle in this brain area was studied by using a spatial discrimination test in a Y-maze. In a first experiment, we observed that when mice had access to morphine (0.1 microgram by injection) they rapidly discriminated the reinforced arm from the neutral arm of the maze in order to self administer, with increasing frequency, the drug into the LH. In contrast when only vehicle was present, the two arms were no longer discriminated. In a second experiment we compared the effects of 3 doses of morphine (0.1 microgram, 0.05 microgram and 0.025 microgram by injection); optimal discrimination was obtained with the lowest dose used. In a third experiment we observed that subcutaneous injections of naloxone (4 mg/kg) progressively reduced the number of self-administrations of morphine into the LH, a result which suggests that this response is dependent on an opiate receptor mechanism.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3620961     DOI: 10.1016/0006-8993(87)90908-5

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  12 in total

1.  Involvement of the lateral hypothalamic peptide orexin in morphine dependence and withdrawal.

Authors:  Dan Georgescu; Venetia Zachariou; Michel Barrot; Michihiro Mieda; Jon T Willie; Amelia J Eisch; Masashi Yanagisawa; Eric J Nestler; Ralph J DiLeone
Journal:  J Neurosci       Date:  2003-04-15       Impact factor: 6.167

2.  Targeting the orexin system for prescription opioid use disorder: Orexin-1 receptor blockade prevents oxycodone taking and seeking in rats.

Authors:  Alessandra Matzeu; Rémi Martin-Fardon
Journal:  Neuropharmacology       Date:  2019-12-04       Impact factor: 5.250

Review 3.  Brain reward circuitry beyond the mesolimbic dopamine system: a neurobiological theory.

Authors:  Satoshi Ikemoto
Journal:  Neurosci Biobehav Rev       Date:  2010-02-10       Impact factor: 8.989

4.  Bilateral intra-accumbens self-administration of d-amphetamine: antagonism with intra-accumbens SCH-23390 and sulpiride.

Authors:  G D Phillips; T W Robbins; B J Everitt
Journal:  Psychopharmacology (Berl)       Date:  1994-04       Impact factor: 4.530

Review 5.  From Molecule to Behavior: Hypocretin/orexin Revisited From a Sex-dependent Perspective.

Authors:  Xiao-Bing Gao; Tamas L Horvath
Journal:  Endocr Rev       Date:  2022-07-13       Impact factor: 25.261

Review 6.  Reward processing by the opioid system in the brain.

Authors:  Julie Le Merrer; Jérôme A J Becker; Katia Befort; Brigitte L Kieffer
Journal:  Physiol Rev       Date:  2009-10       Impact factor: 37.312

7.  Repeated in vivo exposure of cocaine induces long-lasting synaptic plasticity in hypocretin/orexin-producing neurons in the lateral hypothalamus in mice.

Authors:  Yan Rao; Yann S Mineur; Geliang Gan; Alex Hanxiang Wang; Zhong-Wu Liu; Xinyuan Wu; Shigetomo Suyama; Luis de Lecea; Tamas L Horvath; Marina R Picciotto; Xiao-Bing Gao
Journal:  J Physiol       Date:  2013-01-14       Impact factor: 5.182

8.  Orexin mediates the expression of precipitated morphine withdrawal and concurrent activation of the nucleus accumbens shell.

Authors:  Ruth Sharf; Maysa Sarhan; Ralph J Dileone
Journal:  Biol Psychiatry       Date:  2008-04-18       Impact factor: 13.382

Review 9.  Neurocircuitry of drug reward.

Authors:  Satoshi Ikemoto; Antonello Bonci
Journal:  Neuropharmacology       Date:  2013-05-07       Impact factor: 5.250

10.  Rewarding effects elicited by cocaine microinjections into the ventral tegmental area of C57BL/6 mice: involvement of dopamine D1 and serotonin1B receptors.

Authors:  Vincent David; Louis Segu; Marie-Christine Buhot; Marina Ichaye; Pierre Cazala
Journal:  Psychopharmacology (Berl)       Date:  2004-03-13       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.